Chemoprophylaxis for HIV Prevention: New Opportunities and New Questions

被引:7
|
作者
Mayer, Kenneth H. [1 ,2 ]
Venkatesh, Kartik K. [3 ]
机构
[1] Brown Univ, Miriam Hosp, Div Infect Dis, Dept Med,Alpert Med Sch, Providence, RI 02906 USA
[2] Brown Univ, Miriam Hosp, Alpert Med Sch, Dept Community Hlth, Providence, RI 02906 USA
[3] Fenway Inst, Boston, MA USA
关键词
AIDS; ART; HIV; primary prevention; preexposure prophylaxis; postexposure prophylaxis; topical microbicides; NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS; SIMIAN IMMUNODEFICIENCY VIRUS; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; LIMITED KNOWLEDGE; SEMINAL PLASMA; UNITED-STATES; TRANSMISSION; TENOFOVIR; INFECTION;
D O I
10.1097/QAI.0b013e3181fbcb4c
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Growing data suggest that antiretrovirals can be used as an effective means of HIV prevention. This article reviews the current status and future clinical prospects of utilizing antiretroviral chemoprophylaxis before and after high-risk HIV exposure to prevent HIV transmission. The discussion about using antiretrovirals as a means of primary HIV prevention has moved to the forefront of public health discourse because of a growing evidence base, the increased tolerability of the medications, the decreased cost, the ever-expanding formulary, and the limitations of other approaches.
引用
收藏
页码:S122 / S127
页数:6
相关论文
共 50 条
  • [1] ANTIRETROVIRAL CHEMOPROPHYLAXIS: NEW OPPORTUNITIES AND NEW CHALLENGES
    Mayer, K. H.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A7 - A7
  • [2] NextGen HIV prevention: new possibilities and questions
    Mayer, Kenneth H.
    [J]. LANCET, 2016, 387 (10023): : 1036 - 1038
  • [3] Antiretroviral chemoprophylaxis: new successes and questions
    Mayer, Kenneth H.
    [J]. LANCET, 2015, 385 (9984): : 2236 - 2237
  • [4] Antiretroviral Medication and HIV Prevention: New Steps Forward and New Questions
    Mayer, Kenneth H.
    Krakower, Douglas
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 156 (04) : 312 - U105
  • [5] Pathogenesis of HIV disease: Opportunities for new prevention interventions
    Fauci, Anthony S.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 : S206 - S212
  • [6] Acute HIV revisited: new opportunities for treatment and prevention
    Pilcher, CD
    Eron, JJ
    Galvin, S
    Gay, C
    Cohen, MS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (07): : 937 - 945
  • [7] New methods for new questions: Obstacles and opportunities
    Foster, E. Michael
    Kalil, Ariel
    [J]. DEVELOPMENTAL PSYCHOLOGY, 2008, 44 (02) : 301 - 304
  • [8] New opportunities in tuberculosis prevention: implications for people living with HIV
    Fernandez, Lucia Gonzalez
    Casas, Esther C.
    Singh, Satvinder
    Churchyard, Gavin J.
    Brigden, Grania
    Gotuzzo, Eduardo
    Vandevelde, Wim
    Sahu, Suvanand
    Ahmedov, Sevim
    Kamarulzaman, Adeeba
    Ponce-de-Leon, Alfredo
    Grinsztejn, Beatriz
    Swindells, Susan
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 (01)
  • [9] The Medicalization of HIV Prevention: New Opportunities Beset by Old Challenges
    Bayer, Ronald
    [J]. MILBANK QUARTERLY, 2014, 92 (03): : 434 - 437
  • [10] PEP for HIV prevention: are we missing opportunities to reduce new infections?
    Ayieko, James
    Petersen, Maya L.
    Kamya, Moses R.
    Havlir, Diane V.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 (05)